Arthrex ACP Max™ PRP System


The ACP Max™ system allows for collection of 30 mL, 60 mL, or 90 mL of whole blood for the preparation of platelet-rich plasma (PRP). Using a double-spin regimen, this buffy–coat-based system creates a PRP solution depleted of red blood cells and granulocytes, including neutrophils.1 Additional whole blood in the ACP Max PRP system encourages a more concentrated PRP solution and has the capability to create platelet concentrations up to 11 times higher than whole blood alone.1

Reference

1. Arthrex, Inc. Data on file (APT-5535). Naples, FL; 2022.

Category:

Description

 

ACP Max™ Platelet-Rich Plasma System

The ACP Max™ system provides efficient concentration of platelets and growth factors from platelet-rich plasma (PRP) for use at the patient’s point of care. Expanding on the previous generation of PRP devices, the ACP Max system allows for a larger blood draw and provides increased platelet concentration using a unique double-syringe, double-spin design.